The Effects of Tele-Yoga in Ankylosing Spondylitis Patients

May 30, 2022 updated by: Yasemin ACAR, Dokuz Eylul University

The Effects of Tele-Yoga in Ankylosing Spondylitis Patients: A Randomized Controlled Trial

The aim of this study is to investigate the effect of tele-yoga on functional level, disease activity, spinal mobility, balance, aerobic capacity, sleep quality, anxiety, depression, stress, mindfulness and quality of life in patients with ankylosing spondylitis

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Yoga is an ancient discipline that emerged in India thousands of years ago, designed to bring balance and health to the physical, mental, emotional and spiritual dimensions of the individual.Due to its therapeutic effects, yoga can be considered as an alternative approach for those with rheumatic disease. Because of Covid-19, which has changed the world and the lifestyle of people, tele-yoga practice can be considered as an alternative instead of traditional face-to-face yoga classes. The use of online platforms provides a good environment for yoga training at home. The aim of this study is to investigate the effects of tele-yoga on functional level, disease activity, spinal mobility, balance, sleep quality, depression, mindfulness and quality of life in patients with ankylosing spondylitis.

60 AS patients who meet the inclusion criteria will be assigned to the tele-yoga or waiting list control group by the block randomization method. Patients in the tele-yoga group will participate in tele-yoga sessions with a maximum of 5 people in each group by video-conference method for 8 weeks, 3 days a week. Assessments will perform just before starting to study and after the 8-week tele-yoga program. Patients in the waiting list control group will be asked to continue their normal physical activities during the 8-week study, not to start a new exercise program, and to report any changes in the drug or dosage used. Control group's assessments will be performed when they are included in the study and at the end of 8 weeks. After these assessments, patients who wish will participate in the tele-yoga program.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • İzmir, Turkey, 35320
        • Dokuz Eylül University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Ankylosing spondylitis(AS) patients diagnosed according to modified New York criteria
  • To be volunteer
  • To have the necessary equipment to provide internet access and connection

Exclusion Criteria:

  • Presence of systemic, orthopedic neurological or cognitive disease other than ankylosing spondylitis
  • Regular exercise in the last 3 months
  • Pregnancy
  • Not attending 4 consecutive yoga sessions
  • Changing the drug during the study
  • Has an acute attack during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tele-Yoga Group
Patients in the tele-yoga group will participate in tele-yoga sessions with a maximum of 5 people in each group by video-conference method for 8 weeks, 3 days a week. Assessments will perform just before starting to study and after the 8-week tele-yoga program
Tele-yoga training 3 days a week for 8 weeks
No Intervention: Control group
Patients in the waiting list control group will be asked to continue their normal physical activities during the 8-week study, not to start a new exercise program, and to report any changes in the drug or dosage used. Control group's assessments will be performed when they are included in the study and at the end of 8 weeks. After these assessments, patients who wish will participate in the tele-yoga program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bath Ankylosing Spondylitis Functional Index (BASFI)
Time Frame: Change from Baseline at 8 weeks
Assess functional capacity. This self-assessment instrument consists of eight specific questions regarding function in AS and two questions reflecting the patient's ability to cope with everyday life regarding function in AS and two questions reflecting the patient's ability to cope with everyday life.The BASFI score is calculated by dividing the sum of the scores from 10 questions by 10. Score range is 0-10, with 0 reflecting no functional impairments and 10 reflecting maximal impairment.
Change from Baseline at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bath Ankylosing Spondylitis Spinal Metrology Index (BASMI)
Time Frame: Change from Baseline at 8 weeks
Asses spinal mobility. The total score ranges from 0 to 10. Higher scores mean poor spinal mobility.
Change from Baseline at 8 weeks
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
Time Frame: Change from Baseline at 8 weeks
Assess disease activity. The total score ranges from 0 to 10. High scores mean an increase in disease activity.
Change from Baseline at 8 weeks
Assessment of Spondyloarthritis international Society Health Index (ASAS HI)
Time Frame: Change from Baseline at 8 weeks
The ASAS HI contains 17 items (dichotomous response option: 'I agree' and 'I do not agree') addressing different aspects of functioning. The total ASAS HI score is between 0 and 17. Lower score indicates a better and a higher score indicates an inferior health status
Change from Baseline at 8 weeks
Muscular endurance:
Time Frame: Change from Baseline at 8 weeks
Sit-up and push-up tests will be used to evaluate muscular endurance.
Change from Baseline at 8 weeks
Balance
Time Frame: Change from Baseline at 8 weeks
Balance performance will be assessed by the Balance Master System (NeuroCom® International Inc., USA).
Change from Baseline at 8 weeks
Aerobic Capacity
Time Frame: Change from Baseline at 8 weeks
The incremental Shuttle Walk Test will be used to determine aerobic capacity
Change from Baseline at 8 weeks
Pittsburgh Sleep Quality Index
Time Frame: Change from Baseline at 8 weeks
Assess quality of sleep
Change from Baseline at 8 weeks
The Hospital Anxiety And Depression Scale(HADS)
Time Frame: Change from Baseline at 8 weeks
The HADS is a 14-item self-report questionnaire that measures anxiety (7 items) and depression (7 items) symptoms.
Change from Baseline at 8 weeks
Stress
Time Frame: Change from Baseline at 8 weeks
Stress will be assessed with Perceived Stress Scale (PSS).The scale consists of 14 items and total score ranges from 0 to 56. High scores indicate high stress perception.
Change from Baseline at 8 weeks
Mindfulness
Time Frame: Change from Baseline at 8 weeks
Mindful Attention Awareness Scale will be used. The scale consists of 15 items. The total score that can be obtained from the scale is between 15 and 90. High scores reflect more mindfulness.
Change from Baseline at 8 weeks
Short Form-36 (SF-36)
Time Frame: Change from Baseline at 8 weeks
Assess quality of life
Change from Baseline at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: YASEMİN ACAR, Dokuz Eylül University
  • Study Chair: İSMAİL SARI, Dokuz Eylül University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 14, 2021

Primary Completion (Actual)

May 30, 2022

Study Completion (Actual)

May 30, 2022

Study Registration Dates

First Submitted

March 11, 2021

First Submitted That Met QC Criteria

March 16, 2021

First Posted (Actual)

March 17, 2021

Study Record Updates

Last Update Posted (Actual)

June 1, 2022

Last Update Submitted That Met QC Criteria

May 30, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankylosing Spondylitis

Clinical Trials on Tele-yoga

Subscribe